Literature DB >> 21091532

Novel lytic bacteriophages from soil that lyse Burkholderia pseudomallei.

Umaporn Yordpratum1, Unchalee Tattawasart, Surasakdi Wongratanacheewin, Rasana W Sermswan.   

Abstract

Burkholderia pseudomallei is a Gram-negative saprophytic bacterium that causes severe sepsis with a high mortality rate in humans and a vaccine is not available. Bacteriophages are viruses of bacteria that are ubiquitous in nature. Several lysogenic phages of Burkholderia spp. have been found but information is scarce for lytic phages. Six phages, ST2, ST7, ST70, ST79, ST88 and ST96, which lyse B. pseudomallei, were isolated from soil in an endemic area. The phages belong to the Myoviridae family. The range of estimated genome sizes is 24.0-54.6 kb. Phages ST79 and ST96 lysed 71% and 67% of tested B. pseudomallei isolates and formed plaques on Burkholderia mallei but not other tested bacteria, with the exception of closely related Burkholderia thailandensis which was lysed by ST2 and ST96 only. ST79 and ST96 were observed to clear a mid-log culture by lysis within 6 h when infected at a multiplicity of infection of 0.1. As ST79 and ST96 phages effectively lysed B. pseudomallei, their potential use as a biocontrol of B. pseudomallei in the environment or alternative treatment in infected hosts could lead to benefits from phages that are available in nature.
© 2010 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21091532     DOI: 10.1111/j.1574-6968.2010.02150.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  17 in total

1.  Burkholderia pseudomallei is frequently detected in groundwater that discharges to major watercourses in northern Australia.

Authors:  Anthony L Baker; Jeffrey M Warner
Journal:  Folia Microbiol (Praha)       Date:  2015-11-30       Impact factor: 2.099

Review 2.  Emerging role of biologics for the treatment of melioidosis and glanders.

Authors:  Daniel Tapia; Javier I Sanchez-Villamil; Alfredo G Torres
Journal:  Expert Opin Biol Ther       Date:  2019-10-15       Impact factor: 4.388

3.  Molecular Analysis of Arthrobacter Myovirus vB_ArtM-ArV1: We Blame It on the Tail.

Authors:  Laura Kaliniene; Eugenijus Šimoliūnas; Lidija Truncaitė; Aurelija Zajančkauskaitė; Juozas Nainys; Algirdas Kaupinis; Mindaugas Valius; Rolandas Meškys
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

4.  Contributions of P2- and P22-like prophages to understanding the enormous diversity and abundance of tailed bacteriophages.

Authors:  Sherwood R Casjens; Julianne H Grose
Journal:  Virology       Date:  2016-06-30       Impact factor: 3.616

5.  Isolation and characterization of a novel podovirus which infects burkholderia pseudomallei.

Authors:  Jiraporn Gatedee; Kanyanan Kritsiriwuthinan; Edouard E Galyov; Jinyu Shan; Elena Dubinina; Narin Intarak; Martha R J Clokie; Sunee Korbsrisate
Journal:  Virol J       Date:  2011-07-26       Impact factor: 4.099

6.  Temperature dependent bacteriophages of a tropical bacterial pathogen.

Authors:  Jinyu Shan; Sunee Korbsrisate; Patoo Withatanung; Natalie Lazar Adler; Martha R J Clokie; Edouard E Galyov
Journal:  Front Microbiol       Date:  2014-11-14       Impact factor: 5.640

7.  Cloning, expression, and characterization of a peptidoglycan hydrolase from the Burkholderia pseudomallei phage ST79.

Authors:  Nittaya Khakhum; Umaporn Yordpratum; Atcha Boonmee; Unchalee Tattawasart; Jorge L M Rodrigues; Rasana W Sermswan
Journal:  AMB Express       Date:  2016-09-15       Impact factor: 3.298

8.  φX216, a P2-like bacteriophage with broad Burkholderia pseudomallei and B. mallei strain infectivity.

Authors:  Brian H Kvitko; Christopher R Cox; David DeShazer; Shannon L Johnson; Kent J Voorhees; Herbert P Schweizer
Journal:  BMC Microbiol       Date:  2012-12-07       Impact factor: 3.605

9.  Rapid Burkholderia pseudomallei identification and antibiotic resistance determination by bacteriophage amplification and MALDI-TOF MS.

Authors:  Christopher R Cox; Nicholas R Saichek; Herbert P Schweizer; Kent J Voorhees
Journal:  Bacteriophage       Date:  2014-04-25

10.  Experimental Phage Therapy for Burkholderia pseudomallei Infection.

Authors:  Ong Guang-Han; Choh Leang-Chung; Kumutha Malar Vellasamy; Vanitha Mariappan; Chang Li-Yen; Jamuna Vadivelu
Journal:  PLoS One       Date:  2016-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.